In:
Cancer, Wiley, Vol. 106, No. 5 ( 2006-03), p. 1026-1035
Kurzfassung:
To the authors' knowledge, this is the first study to demonstrate that urokinase‐type plasminogen activator (u‐PA) system expression may serve as a predictor of risk in intestinal metaplasia and preoperative biopsy specimens and may have an impact on decision making with regard to neoadjuvant therapy in patients with gastric carcinoma. The results of this independent series demonstrated a correlation between u‐PA system expression and Helicobacter pylori infection, an independent impact of the u‐PA system on tumor recurrence and survival, and a correlation between u‐PAR expression and minimal residual disease.
Materialart:
Online-Ressource
ISSN:
0008-543X
,
1097-0142
Sprache:
Englisch
Verlag:
Wiley
Publikationsdatum:
2006
ZDB Id:
1479932-7
ZDB Id:
2599218-1
ZDB Id:
2594979-2
ZDB Id:
1429-1
